Literature DB >> 28009470

Proportion of circulating tumor cell clusters increases during cancer metastasis.

Yuanzhen Suo1, Chengying Xie1, Xi Zhu1, Zhichao Fan1, Zhangru Yang1, Hao He1, Xunbin Wei1.   

Abstract

Circulating tumor cell (CTC) clusters are found among CTCs and show significantly greater potential for an important role in cancer metastasis than single CTCs, which have been traditionally believed as the majority of CTCs. The accurate proportion and dynamics of CTC clusters remain unclear due to the fact that CTCs in blood flow are very difficult to detect in vivo and in vitro. CTC clusters are even more difficult to be distinguished from CTCs without perturbation by state-of-the-art detection methods. Here, we demonstrate that by using in vivo flow cytometry (IVFC), we can reliably measure the proportion and dynamics of CTC clusters in two murine tumor models. CTC clusters are easily identified by their unique fluorescent pattern with multiple peaks and wider time duration. We find that the proportion of CTC clusters increases significantly during cancer metastasis in both mouse models, the orthotopic liver cancer and the subcutaneous prostate cancer models. Our results suggest that CTC clusters account for a much larger proportion of CTCs than previously anticipated. Hence this report might provide a new-level of understanding of CTCs during cancer development and progression.
© 2016 International Society for Advancement of Cytometry. © 2016 International Society for Advancement of Cytometry.

Entities:  

Keywords:  cancer metastasis; circulating tumor cell; in vivo flow cytometry; murine tumor models

Mesh:

Year:  2016        PMID: 28009470     DOI: 10.1002/cyto.a.23037

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  16 in total

Review 1.  Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.

Authors:  Jill M Pulley; Rebecca N Jerome; Martin L Ogletree; Gordon R Bernard; Robert R Lavieri; Nicole M Zaleski; Charles C Hong; Jana K Shirey-Rice; Carlos L Arteaga; Ingrid A Mayer; Kenneth J Holroyd; Rebecca S Cook
Journal:  Target Oncol       Date:  2018-02       Impact factor: 4.493

2.  Circulating Tumor Cells as an Indicator of Treatment Options for Hepatocellular Carcinoma Less Than or Equal to 3 cm in Size: A Multi-Center, Retrospective Study.

Authors:  Qiao Zhang; Feng Xia; Hengyi Gao; Zhenheng Wu; Wenjing Cao; Qingfeng Xiang; Zhifeng Guan; Yang Su; Weiqiao Zhang; Weiqiang Chen; Ali Mo; Shuqun Li
Journal:  Front Surg       Date:  2022-06-20

3.  Fluorescence detection, enumeration and characterization of single circulating cells in vivo: technology, applications and future prospects.

Authors:  Carolin Hartmann; Roshani Patil; Charles P Lin; Mark Niedre
Journal:  Phys Med Biol       Date:  2017-12-14       Impact factor: 3.609

Review 4.  Tumor circulome in the liquid biopsies for digestive tract cancer diagnosis and prognosis.

Authors:  Long Chen; Yu Chen; Yuan-Ling Feng; Yan Zhu; Li-Quan Wang; Shen Hu; Pu Cheng
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

5.  Heterogeneity of circulating tumor cell dissemination and lung metastases in a subcutaneous Lewis lung carcinoma model.

Authors:  Jessica E Fitzgerald; Brook K Byrd; Roshani A Patil; Rendall R Strawbridge; Scott C Davis; Chiara Bellini; Mark Niedre
Journal:  Biomed Opt Express       Date:  2020-06-08       Impact factor: 3.732

6.  Detection of Apoptotic Circulating Tumor Cells Using in vivo Fluorescence Flow Cytometry.

Authors:  Jacqueline Nolan; Dmitry A Nedosekin; Ekaterina I Galanzha; Vladimir P Zharov
Journal:  Cytometry A       Date:  2018-12-03       Impact factor: 4.714

7.  Simultaneous Multiparameter Cellular Energy Metabolism Profiling of Small Populations of Cells.

Authors:  Laimonas Kelbauskas; Shashaanka P Ashili; Kristen B Lee; Haixin Zhu; Yanqing Tian; Deirdre R Meldrum
Journal:  Sci Rep       Date:  2018-03-12       Impact factor: 4.379

8.  In Vitro Model-Systems to Understand the Biology and Clinical Significance of Circulating Tumor Cell Clusters.

Authors:  Alexander N May; Bryan D Crawford; Aurora M Nedelcu
Journal:  Front Oncol       Date:  2018-03-12       Impact factor: 6.244

9.  Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.

Authors:  Vishnu C Ramani; Clementine A Lemaire; Melanie Triboulet; Kerriann M Casey; Kyra Heirich; Corinne Renier; José G Vilches-Moure; Rakhi Gupta; Aryana M Razmara; Haiyu Zhang; George W Sledge; Elodie Sollier; Stefanie S Jeffrey
Journal:  Breast Cancer Res       Date:  2019-08-28       Impact factor: 6.466

10.  Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer.

Authors:  Aryana M Razmara; Elodie Sollier; Grace N Kisirkoi; Sam W Baker; Margot B Bellon; Alex McMillan; Clementine A Lemaire; Vishnu C Ramani; Stefanie S Jeffrey; Kerriann M Casey
Journal:  Clin Exp Metastasis       Date:  2020-04-25       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.